These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 27904159)

  • 1. Copeptin as a biomarker for prediction of prognosis of acute ischemic stroke and transient ischemic attack: a meta-analysis.
    Xu Q; Tian Y; Peng H; Li H
    Hypertens Res; 2017 May; 40(5):465-471. PubMed ID: 27904159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.
    De Marchis GM; Weck A; Audebert H; Benik S; Foerch C; Buhl D; Schuetz P; Jung S; Seiler M; Morgenthaler NG; Mattle HP; Mueller B; Christ-Crain M; Arnold M; Katan M
    Stroke; 2014 Oct; 45(10):2918-23. PubMed ID: 25169950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copeptin and Long-Term Risk of Recurrent Vascular Events After Transient Ischemic Attack and Ischemic Stroke: Population-Based Study.
    Greisenegger S; Segal HC; Burgess AI; Poole DL; Mehta Z; Rothwell PM
    Stroke; 2015 Nov; 46(11):3117-23. PubMed ID: 26451023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma copeptin and functional outcome in patients with ischemic stroke and type 2 diabetes.
    Wang CB; Zong M; Lu SQ; Tian Z
    J Diabetes Complications; 2016; 30(8):1532-1536. PubMed ID: 27554438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copeptin Levels in Patients With Acute Ischemic Stroke and Stroke Mimics.
    Wendt M; Ebinger M; Kunz A; Rozanski M; Waldschmidt C; Weber JE; Winter B; Koch PM; Nolte CH; Hertel S; Ziera T; Audebert HJ;
    Stroke; 2015 Sep; 46(9):2426-31. PubMed ID: 26251255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke.
    Katan M; Fluri F; Morgenthaler NG; Schuetz P; Zweifel C; Bingisser R; Müller K; Meckel S; Gass A; Kappos L; Steck AJ; Engelter ST; Müller B; Christ-Crain M
    Ann Neurol; 2009 Dec; 66(6):799-808. PubMed ID: 20035506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk study.
    De Marchis GM; Katan M; Weck A; Brekenfeld C; Mattle HP; Buhl D; Müller B; Christ-Crain M; Arnold M
    Int J Stroke; 2013 Apr; 8(3):214-8. PubMed ID: 22336226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of copeptin: one-year outcome in patients with acute stroke.
    Urwyler SA; Schuetz P; Fluri F; Morgenthaler NG; Zweifel C; Bergmann A; Bingisser R; Kappos L; Steck A; Engelter S; Müller B; Christ-Crain M; Katan M
    Stroke; 2010 Jul; 41(7):1564-7. PubMed ID: 20508186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic and prognostic value of copeptin in patients with acute ischemic stroke and transient ischemic attack: A systematic review and meta-analysis.
    Blek N; Szwed P; Putowska P; Nowicka A; Drela WL; Gasecka A; Ladny JR; Merza Y; Jaguszewski MJ; Szarpak L
    Cardiol J; 2022; 29(4):610-618. PubMed ID: 35621091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke.
    Tu WJ; Dong X; Zhao SJ; Yang DG; Chen H
    J Neuroendocrinol; 2013 Sep; 25(9):771-8. PubMed ID: 23701638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic role of resistin and copeptin in acute ischemic stroke.
    Perovic E; Mrdjen A; Harapin M; Tesija Kuna A; Simundic AM
    Top Stroke Rehabil; 2017 Dec; 24(8):614-618. PubMed ID: 28845746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma copeptin and long-term outcomes in acute ischemic stroke.
    Zhang JL; Yin CH; Zhang Y; Zhao LB; Fu HJ; Feng JC
    Acta Neurol Scand; 2013 Dec; 128(6):372-80. PubMed ID: 23614762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The determination of copeptin levels helps management decisions among transient ischaemic attack patients.
    Purroy F; Suárez-Luis I; Cambray S; Farré J; Benabdelhak I; Mauri-Capdevila G; Sanahuja J; Quílez A; Begué R; Gil MI; Molina-Seguin J; Torreguitart N
    Acta Neurol Scand; 2016 Aug; 134(2):140-7. PubMed ID: 26471428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Level and Increase in D-Dimer With All-Cause Death and Poor Functional Outcome After Ischemic Stroke or Transient Ischemic Attack.
    Hou H; Xiang X; Pan Y; Li H; Meng X; Wang Y
    J Am Heart Assoc; 2021 Feb; 10(3):e018600. PubMed ID: 33412918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of copeptin in patients with acute stroke.
    Jiao L; Chu C; Zhou S
    Expert Rev Neurother; 2015 May; 15(5):563-70. PubMed ID: 25865618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.
    De Marchis GM; Katan M; Weck A; Fluri F; Foerch C; Findling O; Schuetz P; Buhl D; El-Koussy M; Gensicke H; Seiler M; Morgenthaler N; Mattle HP; Mueller B; Christ-Crain M; Arnold M
    Neurology; 2013 Apr; 80(14):1278-86. PubMed ID: 23468541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke.
    Tu WJ; Ma GZ; Ni Y; Hu XS; Luo DZ; Zeng XW; Liu Q; Xu T; Yu L; Wu B
    Neurology; 2017 May; 88(20):1899-1905. PubMed ID: 28424274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of copeptin predict 1-year mortality in patients with acute ischemic stroke.
    Wang CW; Wang JL; Zhang Y; Li Q; Guo SX; Ji SB
    Neuroreport; 2014 Dec; 25(18):1447-52. PubMed ID: 25383462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Neurofilament Light Chain as a Predictive Biomarker for Ischemic Stroke Outcome: A Systematic Review and Meta-analysis.
    Liu D; Chen J; Wang X; Xin J; Cao R; Liu Z
    J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104813. PubMed ID: 32305278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress hormones predict cerebrovascular re-events after transient ischemic attacks.
    Katan M; Nigro N; Fluri F; Schuetz P; Morgenthaler NG; Jax F; Meckel S; Gass A; Bingisser R; Steck A; Kappos L; Engelter S; Müller B; Christ-Crain M
    Neurology; 2011 Feb; 76(6):563-6. PubMed ID: 21228295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.